{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:51:39Z","timestamp":1783036299570,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.gim.2021.10.016","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T10:17:41Z","timestamp":1638526661000},"page":"564-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeted BRCA1\/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study"],"prefix":"10.1016","volume":"24","author":[{"given":"Kelly M.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jada G.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Symecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Kamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Spielman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia E.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince Rainier","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Braswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Marcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temima","family":"Wildman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Devolder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Camhi","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Fesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylin","family":"Boehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Heitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gim.2021.10.016_bib1","series-title":"Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation","article-title":"U.S. Preventive Services Task Force Evidence Synthesis, formerly Systematic Evidence Reviews","author":"Nelson","year":"2013"},{"issue":"7","key":"10.1016\/j.gim.2021.10.016_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1055-9965.EPI-12-0149","article-title":"A\u00a0simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers","volume":"21","author":"Sigal","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.gim.2021.10.016_bib3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","article-title":"Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers","volume":"19","author":"Drohan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gim.2021.10.016_bib4","unstructured":"PDQ\u00ae Cancer Genetics Editorial Board. Cancer genetics risk assessment and counseling (PDQ\u00ae) - Health Professional Version. National Cancer Institute. https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/genetics\/risk-assessment-pdq. Accessed September 15, 2020."},{"issue":"5","key":"10.1016\/j.gim.2021.10.016_bib5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s10897-016-9932-2","article-title":"Analysis of advantages, limitations, and barriers of genetic counseling service delivery models","volume":"25","author":"Cohen","year":"2016","journal-title":"J\u00a0Genet Couns"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10897-017-0158-8","article-title":"Projecting the supply and demand for certified genetic counselors: a workforce study","volume":"27","author":"Hoskovec","year":"2018","journal-title":"J\u00a0Genet Couns"},{"issue":"9","key":"10.1016\/j.gim.2021.10.016_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.11137","article-title":"Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing","volume":"318","author":"Mandelker","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.gim.2021.10.016_bib8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.19.02010","article-title":"Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening","volume":"38","author":"Offit","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jnci\/dju420","article-title":"Precision medicine meets public health: population screening for BRCA1 and BRCA2","volume":"107","author":"Levy-Lahad","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.gim.2021.10.016_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.gim.2021.10.016_bib11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.gim.2021.10.016_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group","volume":"83","year":"2000","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.gim.2021.10.016_bib13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/gim.2016.182","article-title":"Population screening for BRCA1\/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral","volume":"19","author":"Lieberman","year":"2017","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.gim.2021.10.016_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2009.25.0712","article-title":"Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women","volume":"28","author":"Metcalfe","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.gim.2021.10.016_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/bjc.2013.309","article-title":"A\u00a0comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing","volume":"109","author":"Metcalfe","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/dju379","article-title":"Population testing for\u00a0cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial","volume":"107","author":"Manchanda","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.gim.2021.10.016_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/gim.2016.154","article-title":"Experiences from a pilot program bringing BRCA1\/2 genetic screening to the US Ashkenazi Jewish population","volume":"19","author":"Wiesman","year":"2017","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2021.10.016_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/gim.2016.175","article-title":"Population screening for BRCA1\/BRCA2 mutations: lessons from qualitative analysis of the screening experience","volume":"19","author":"Lieberman","year":"2017","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.gim.2021.10.016_bib19","doi-asserted-by":"crossref","first-page":"578.e1","DOI":"10.1016\/j.ajog.2017.06.038","article-title":"Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry","volume":"217","author":"Manchanda","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gim.2021.10.016_bib20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines Insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.gim.2021.10.016_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.10142","article-title":"USPSTF Recommendations for BRCA1 and BRCA2 testing in the context of a transformative national cancer control plan","volume":"2","author":"Rajagopal","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.gim.2021.10.016_bib22","first-page":"340","article-title":"Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers","volume":"32","author":"Swink","year":"2019","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"3","key":"10.1016\/j.gim.2021.10.016_bib23","first-page":"101","article-title":"Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market","volume":"1","author":"Borry","year":"2010","journal-title":"J\u00a0Community Genet"},{"issue":"12","key":"10.1016\/j.gim.2021.10.016_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/gim.2018.38","article-title":"False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care","volume":"20","author":"Tandy-Connor","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2021.10.016_bib25","doi-asserted-by":"crossref","first-page":"l5688","DOI":"10.1136\/bmj.l5688","article-title":"Direct-to-consumer genetic testing","volume":"367","author":"Horton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.gim.2021.10.016_bib26","series-title":"Exploring the Current Landscape of Consumer Genomics: Proceedings of a Workshop","year":"2020"},{"key":"10.1016\/j.gim.2021.10.016_bib27","unstructured":"Pace L, Tung N, Hamilton JG, et\u00a0al. Challenges and opportunities in engaging primary care providers in BRCA testing: early results from the BFOR study. Paper Presented at: Society for General Internal Medicine Annual Meeting; May 8-11, 2019; Washington, DC."},{"key":"10.1016\/j.gim.2021.10.016_bib28","article-title":"Challenges and opportunities in engaging primary care providers in BRCA testing: results from the BFOR study","author":"Pace","year":"2021","journal-title":"J\u00a0Gen Intern Med"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.31486\/toj.19.0055","article-title":"Revised common rule changes to the consent process and consent form","volume":"20","author":"LeCompte","year":"2020","journal-title":"Ochsner J"},{"issue":"2","key":"10.1016\/j.gim.2021.10.016_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","article-title":"Genetic\/familial high-risk assessment: breast and ovarian, version 2.2015","volume":"14","author":"Daly","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12874-020-01086-9","article-title":"Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial","volume":"20","author":"Pace","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"26","key":"10.1016\/j.gim.2021.10.016_bib32","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible - the neighborhood atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gim.2021.10.016_bib33","unstructured":"Area Deprivation Index V3.0. University of Wisconsin School of Medicine and Public Health. https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/. Accessed May 1, 2021."},{"key":"10.1016\/j.gim.2021.10.016_bib34","unstructured":"Eckstein Y. Genetic testing? Only when it will do no harm. AMI Living. Published December 28, 2016. https:\/\/doryeshorim.org\/wp-content\/uploads\/2017\/01\/liv299_MyTake.pdf. Accessed August 26, 2020."},{"issue":"6","key":"10.1016\/j.gim.2021.10.016_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.6004\/jnccn.2016.0081","article-title":"Population-based BRCA1\/2 testing in Ashkenazi Jews: ready for prime time","volume":"14","author":"Lynce","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.gim.2021.10.016_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/1471-0528.15654","article-title":"Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study","volume":"126","author":"Manchanda","year":"2019","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/healthcare4010019","article-title":"Public health approaches and barriers to educating providers about hereditary breast and ovarian cancer syndrome","volume":"4","author":"Trepanier","year":"2016","journal-title":"Healthcare (Basel)"},{"issue":"5","key":"10.1016\/j.gim.2021.10.016_bib38","first-page":"327","article-title":"Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine","volume":"61","author":"Weitzel","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.gim.2021.10.016_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1186\/s12913-019-4679-8","article-title":"Are\u00a0providers prepared for genomic medicine: interpretation of direct-to-consumer genetic testing (DTC-GT) results and genetic\u00a0self-efficacy by medical professionals","volume":"19","author":"McGrath","year":"2019","journal-title":"BMC Health Serv\u00a0Res"},{"issue":"5","key":"10.1016\/j.gim.2021.10.016_bib40","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/ajmg.a.36453","article-title":"Genetic counselor review of genetic test orders in a reference laboratory reduces unnecessary testing","volume":"164A","author":"Miller","year":"2014","journal-title":"Am J Med Genet A"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021053685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021053685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:52:29Z","timestamp":1761097949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021053685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1098360021053685"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2021.10.016","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted BRCA1\/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2021.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}]}}